Brief: Pharmasimple Announces Strategic Diversification Into OTC Drugs From 2021
17/11/2020 17:11
Nov 17 (Reuters) - PHARMASIMPLE SA ALPHS.PA :
* ANNOUNCES STRATEGIC DIVERSIFICATION INTO OTC DRUGS FROM
2021
* DEPENDING ON SUCCESS OF INITIATIVE, PHARMASIMPLE WILL
RAPIDLY
EXPAND ITS SALES OF OTC DRUGS IN FRANCE BY RELYING ON ITS
1001PHARMACIES.COM NETWORK
Source text: https://bit.ly/3f8Tfs3
Further company coverage: ALPHS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Pharmasimple SA
See all newsBrief: Pharmasimple Says It Received Order To Suspend Stock Consolidation
Brief: Pharmasimple Says Stock Consolidation Approved
Brief: Pharmasimple H1 EBITDA Loss Widens To 3.6 Million Euros
Brief: Pharmasimple Announces Reverse Stock Split
Brief: Pharmasimple: Suspension Of OCA Drawdowns From Oct For At Least 6 Months